Association of Polymorphism in Gene of Pregnancy-Associated Plasma Protein A (PAPPA) and Preeclampsia

Nasrin Moghaddam, Maryam Karimi, Ahmad Ebrahimi

Abstract


Background: Preeclampsia is a common disorder of pregnancy. Current study was conducted to determine the association of polymorphism in gene of pregnancy-associated plasma protein A (PAPPA) and preeclampsia.

Methods: In this prospective cohort study, 134 pregnant women were consecutively enrolled and the blood sampling was performed for genetic analysis in a single lab. Then the subjects were followed-up for preeclampsia and it was seen that 34 women developed preeclampsia and the polymorphism of PAPPA gene was compared between those with and without preeclampsia.

Results: The results demonstrated that despite twice higher proportion of CC condition of PAPPA in those with preeclampsia in comparison with those with normal pregnancy, there was no significant difference between two groups (P > 0.05).

Conclusions: Totally, according to the obtained results, it may be concluded that polymorphism of pregnancy-associated plasma protein A is not related to occurrence of preeclampsia in pregnant women.


Keywords


Pregnancy-associated plasma protein A, Preeclampsia, Pregnancy

Full Text:

PDF

References


Rath W, Fischer T. The diagnosis and treatment of hypertensive disorders of pregnancy: new findings for antenatal and inpatient care. Dtsch Arztebl Int. 2009 Nov; 106(45):733-8.

Chandiramani M, Shennan A. Hypertensive disorders of pregnancy: a UK-based perspective. Curr Opin Obstet Gynecol. 2008;20:96-101.

Brown MA, Lindheimer MD, de Swiet M, van Assche A, Moutquin J-M. The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy. Hypertension in Pregnancy. 2001;20:ix-xiv.

Report of the National High Blood Pressure Education program. Working group report on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000; 183:181-92.

Cunningham GW. Reach JD. Textbook of gynecology and obstetrics. 2010; 1263.

Erez O, Romero R, Espinoza J, et al. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. J Matern Fetal Neonatal Med. 2008 May;21(5):279-87.

Genis AB, Conover CA, Overgaard MT, Bailey KR, Christiansen M, Holmes DR. Pregnancy-Associated Plasma Protein A as a Marker of Acute Coronary Syndromes. N Engl J Med 2001; 345:1022-9.

Carty DM, Delles C, Dominiczak AF. Novel Biomarkers for Predicting Preeclampsia: Trends Cardiovasc Med. 2008 July; 18(5-24): 186-94.

Barton JR, Sibai BM. Prediction and prevention of recurrent preeclampsia. Obstet Gynecol. 2008; 112:359-72.

Papageorghiou AT. Predicting and presenting preeclampsia—where to next? Ultrasound Obstet Gynecol. 2008; 31:367-70.

Muravská A, Germanová A, Jáchymová M, et al. Association of pregnancy-associated plasma protein A polymorphism with preeclampsia - A pilot study. Clin Biochem. 2011 (4).1380-4.

Dane B, Dane C, Kiray M, Cetin A, Koldas M, Erginbas M. Correlation between first-trimester maternal serum markers, second-trimester uterine artery doppler indices and pregnancy outcome. Gynecol Obstet Invest. 2010;70(2):126-31.

Morssink LP, Kornman LH, Hallahan TW, et al. Maternal serum levels of free beta-hCG and PAPP-A in the first trimester of pregnancy are not associated with subsequent fetal growth retardation or preterm delivery. Prenat Diagn. 1998 Feb;18(2):147-52.

Spencer K, Yu CK, Cowans NJ, Otigbah C, Nicolaides KH. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler. Prenat Diagn. 2005 Oct;25(10):949-53.

Pilalis A, Souka AP, Antsaklis P, et al. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks' gestation. Ultrasound Obstet Gynecol. 2007 Feb;29(2):135-40.

Ertl R, Yu CK, Samaha R, Akolekar R, Nicolaides KH. Maternal serum vitamin D at 11-13 weeks in pregnancies delivering small for gestational age neonates. Fetal Diagn Ther. 2012;31(2):103-8.

Ardawi MS, Nasrat HA, Rouzi AA, et al. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women. Prenat Diagn. 2007 Apr;27(4):303-11.

Germanová A, Jáchymová M, Koucký M, Hájek Z, Zima T, Kalousová M. Pregnancy-associated plasma protein A polymorphisms in patients with risk pregnancies. Folia biologica. 2011; 57(2):82-5.

Crosley EJ, Durland U, Seethram K, Macrae S, Gruslin A, Christians JK. First-Trimester Levels of Pregnancy-Associated Plasma Protein A2 (PAPP-A2) in the Maternal Circulation Are Elevated in Pregnancies That Subsequently Develop Preeclampsia. Reproductive sciences (Thousand Oaks, Calif.) 2013; DOI:10.1177/1933719113512532

Spencer K, Cowans NJ, Nicolaides KH. Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia. Prenatal Diagnosis. 2008; 28(1):7-10.




DOI: http://dx.doi.org/10.7575/aiac.abcmed.v.6n.1p.15

Refbacks

  • There are currently no refbacks.




Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

2013-2019 (CC-BY) Australian International Academic Centre PTY.LTD.

Advances in Bioscience and Clinical Medicine